Business Context and Reporting Period
This Form 8-K Current Report was filed by AudioEye, Inc. on December 9, 2016, covering events that occurred on December 7, 2016. The filing primarily addresses executive compensation adjustments and equity grants designed to preserve the company's limited cash resources.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, or cash flow data. However, it discloses specific compensation-related financial figures:
- Executive Cash Compensation: Dr. Carr Bettis (Executive Chairman) was owed $72,917 for services rendered from July 1, 2016, through November 30, 2016.
- Stock Valuation: The 10-day average closing price of Common Stock used for award pricing was $0.121 (calculated from November 17, 2016).
- Open Market Purchases: Dr. Bettis purchased 213,300 shares between November 18, 2016, and December 6, 2016, at prices ranging from $0.1199 to $0.14 per share.
- Liquidity Context: The company explicitly states it is preserving "limited cash resources" by paying base compensation in Restricted Stock Units (RSUs) rather than cash.
Material Changes
The following material changes to executive compensation and equity structure were approved on December 7, 2016:
- Dr. Carr Bettis (Executive Chairman):
- Employment contract extended and modified.
- Base compensation converted to RSUs to conserve cash.
- Granted 602,620 RSUs to settle accrued compensation ($72,917).
- Granted an additional long-term equity award of 250,000 shares (subject to reduction by prior awards).
- Todd Bankofier (CEO):
- Base annual salary increased to $175,000.
- Granted 250,000 RSUs (subject to reduction by prior awards).
Guidance, Outlook, and Risks
Management Commentary: The Board, acting on recommendations from the Compensation Committee and outside consultants, structured these awards to align executive interests with a potential change of control while minimizing immediate cash outflows.
Vesting Conditions: All new RSU grants to Dr. Bettis and Mr. Bankofier are subject to two strict conditions:
- Continuous service through June 30, 2017.
- A change of control must occur during the seven-year term of the award.
Risks: The reliance on equity for base compensation highlights liquidity constraints. The vesting of significant equity is contingent on a change of control, indicating the company may be positioning for a sale or merger.
Investor Verification Checklist
- Verify the company's current cash position and runway given the explicit mention of "limited cash resources."
- Confirm the status of the "Performance Option Unit Agreements" granted in January 2016, as they reduce the share count of the new RSU awards.
- Monitor for any announcements regarding a change of control, as this is a mandatory vesting condition for the new equity grants.
- Review the total dilution impact of the 1,102,620 RSUs granted to Dr. Bettis and the 250,000 RSUs granted to Mr. Bankofier.